Body composition analysis using abdominal scans from routine clinical care in patients with Crohn’s Disease

References

• Krok KL, Lichtenstein GR. Nutrition in Crohn disease. Curr Opin Gastroenterol. 2003;19:148–153.
   PubMed Web of Science ®Google Scholar
• Alastair F, Emma G, Emma P. Nutrition in inflammatory bowel disease. J Parenter Enteral Nutr. 2011;35:571–580.
   PubMed Web of Science ®Google Scholar
• Bin CM, Flores C, Álvares-Da-Silva MR, et al. Comparison between handgrip strength, subjective global assessment, anthropometry, and biochemical markers in assessing nutritional status of patients with Crohn’s disease in clinical remission. Dig Dis Sci. 2010;55:137–144.
   PubMed Web of Science ®Google Scholar
• Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561–569.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003;124:795–841.
   PubMed Web of Science ®Google Scholar
• Tjellesen L, Nielsen PK, Staun M. Body composition by dual-energy X-ray absorptiometry in patients with Crohn's disease. Scand J Gastroenterol. 1998;33:956–960.
   PubMed Web of Science ®Google Scholar
• Kyle UG, Unger P, Mensi N, et al. Nutrition status in patients younger and older than 60 y at hospital admission: a controlled population study in 995 subjects. Nutrition. 2002;18:463–469.
   PubMed Web of Science ®Google Scholar
• Bryant RV, Trott MJ, Bartholomeusz FD, et al. Systematic review: body composition in adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:213–225.
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, Adamek M, Gonzalez MC, et al. Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle. 2014;5:9–18.
   PubMed Web of Science ®Google Scholar
• Reid IR, Ames R, Evans MC, et al. Determinants of total body and regional bone mineral density in normal postmenopausal women – a key role for fat mass. J Clin Endocrinol Metab. 1992;75:45–51.
   PubMed Web of Science ®Google Scholar
• American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastoenterology. 2003;124:791–794.
   PubMedGoogle Scholar
• Etzel JP, Larson MF, Anawalt BD, et al. Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis. 2011;17:2122–2129.
   PubMed Web of Science ®Google Scholar
• Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2008;103:2015–2022.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CMM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997–1006.
   PubMed Web of Science ®Google Scholar
• Baker ST, Strauss BJ, Prendergast LA, et al. Estimating dual-energy X-ray absorptiometry-derived total body skeletal muscle mass using single-slice abdominal magnetic resonance imaging in obese subjects with and without diabetes: a pilot study. Eur J Clin Nutr. 2012;66:628–632.
   PubMed Web of Science ®Google Scholar
• Shen W, Punyanitya M, Wang Z, et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr. 2004;80:271–278.
   PubMed Web of Science ®Google Scholar
• Shen W, Wang Z, Punyanita M, et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res. 2003;11:5–16.
   PubMedGoogle Scholar
• Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283–286.
   PubMed Web of Science ®Google Scholar
• Schweitzer L, Geisler C, Pourhassan M, et al. What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults? Am J Clin Nutr. 2015;102:58–65.
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. Automatic Control. 1974;6:716–723.
   Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–763.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423.
   PubMed Web of Science ®Google Scholar
• Bryant RV, Ooi S, Schultz CG, et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41:895–906.
   PubMed Web of Science ®Google Scholar
• Schneider SM, Al-Jaouni R, Filippi J, et al. Sarcopenia is prevalent in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis. 2008;14:1562–1568.
   PubMed Web of Science ®Google Scholar
• Subramaniam K, Fallon K, Ruut T, et al. Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease. Aliment Pharmacol Ther. 2015;41:419–428.
   PubMed Web of Science ®Google Scholar
• Fong Y, Moldawer LL, Marano M, et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol. 1989;256:R659–R665.
   PubMed Web of Science ®Google Scholar
• Roubenoff R, Roubenoff RA, Cannon JG, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest. 1994;93:2379–2386.
   PubMed Web of Science ®Google Scholar
• Haehling von S, Anker SD. Treatment of cachexia: an overview of recent developments. Int J Cardiol. 2014;184:736–742.
   PubMed Web of Science ®Google Scholar
• Morley JE, Thomas DR, Wilson M-MG. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735–743.
   PubMed Web of Science ®Google Scholar
• Masuko K. Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis. Front Nutr. 2014;1(Suppl 3):20.
   PubMedGoogle Scholar
• Blain A, Cattan S, Beaugerie L, et al. Crohn's disease clinical course and severity in obese patients. Clin Nutr. 2002;21:51–57.
   PubMed Web of Science ®Google Scholar
• Leslie WD, Miller N, Rogala L, et al. Body mass and composition affect bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Inflamm Bowel Dis. 2009;15:39–46.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Leslie WD. Review article: osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;19:941–952.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Irving PM. Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to? J Gastroenterol Hepatol. 2009;24:1160–1162.
   PubMed Web of Science ®Google Scholar
• Australian Health Survey: First Results, 2011–12. ausstats.abs.gov.au. Australian Bureau of Statistics; 2012 Oct. Report No.: 4364.0.55.001.
   Google Scholar